Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Quick Links Investor Presentation Responsibility News Portfolio Responsibility Report Annual Reports Leadership Governance SEC Filings Latest Press Releases July 9, 2024 Incyte to Report Second Quarter Financial Results July 8, 2024 Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 13, 2024 Incyte Announces Final Results of Tender Offer All press releases Latest Events Jul 30 2024 Jul 30 2024 Q2 2024 Incyte Corporation Earnings Conference Call click here for Webcast Jun 10 2024 Jun 10 2024 Goldman Sachs Global Healthcare Conference Click here for Webcast All events